Fact CheckerSign in

NCT06227494Active, not recruiting

Dietary Fiber: Is it the Missing Link in Achieving Long Term Behavior Change?

Source: ClinicalTrials.gov · Last updated 29 Sept 2025

Brief summary (registry, in English)

The overall objective of this three-arm randomized controlled trial is to compare a dietary fiber-focused behavioral intervention to standard weight loss education for improving eating-related behavior and cognition, weight, and metabolic markers of chronic disease risk in a population of adults with obesity.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
63 (actual)
First submitted
28 Jul 2023
Start date
Jul 2023
Primary completion date
Jan 2026
Lead sponsor
Oklahoma State University
Diseases
Obesity
NCT number
NCT06227494

What you commit to

  • Study type: Interventional
  • Participants enrolled: 63
  • From Jul 2023 to the primary completion date, Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently taking glucagon like glucagon-like peptide-1 (GLP-1) Receptor Agonists

Other illness

  • Metabolic, digestive, or allergic conditions or reactions that preclude consumption of whole food or food groups (e.g., irritable bowel syndrome, diverticulosis)
  • History of gastric bypass surgery
  • Self-reported history of a diagnosed eating disorder
  • Chronic disease (other than obesity)

Other

  • Pregnancy or lactation
  • Use of tobacco or electronic smoking products
  • Taking a pre-, pro-, or syn-biotic supplement
  • Enrollment in another weight loss or diet intervention

Who the study is looking for

  • 18-65 years of age
  • Dietary fiber intake ≤25 grams/day
  • Self-reported BMI ≥30 kg/m2
  • Willingness to attend in-person education sessions
  • Willingness to avoid taking supplemental digestive aids (e.g., alpha-galactosidase (Beano®),
  • Willingness to provide informed consent.

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Oklahoma State University
Coordinator of this site? Confirm its status
StillwaterUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.